For research use only. Not for therapeutic Use.
MALAT1-IN-1 (compounds 5) is a potent and specific Malat1 (Metastasis-associated lung adenocarcinoma transcript 1) inhibitor. MALAT1-IN-1 modulated Malat1 downstream genes in a dose-dependent manner without affecting expression of nuclear enriched abundant transcript 1 (Neat1) [1].
MALAT1-IN-1 (Compound 5) (1 μM, 7 days) reduces Malat1 levels and mammary tumor organoid branching in an organoid model of mammary cancer derived from MMTV-PyMT luminal B tumors in mice[1].
MALAT1-IN-1 (0.5 and 1 μM) inhibits downstream targets of Malat1 (krt16) and increases csn2 in MMTV-PyMT tumor organoids[1].
Catalog Number | I017976 |
CAS Number | 827327-28-6 |
Synonyms | 5-(4-methoxyphenyl)-N-[(3-methoxyphenyl)methyl]-1-methylimidazol-2-amine |
Molecular Formula | C19H21N3O2 |
Purity | ≥95% |
InChI | InChI=1S/C19H21N3O2/c1-22-18(15-7-9-16(23-2)10-8-15)13-21-19(22)20-12-14-5-4-6-17(11-14)24-3/h4-11,13H,12H2,1-3H3,(H,20,21) |
InChIKey | LCVOJBGSGIOMKF-UHFFFAOYSA-N |
SMILES | CN1C(=CN=C1NCC2=CC(=CC=C2)OC)C3=CC=C(C=C3)OC |
Reference | [1]. Abulwerdi FA, et al. Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1. ACS Chem Biol. 2019 Feb 15;14(2):223-235. |